We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$483M
AUM Growth
+$73.4M
Cap. Flow
+$54.1M
Cap. Flow %
11.2%
Top 10 Hldgs %
36.82%
Holding
132
New
23
Increased
33
Reduced
45
Closed
4

Top Buys

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$10.1M
2
T icon
AT&T
T
+$9.79M
3
XOM icon
ExxonMobil
XOM
+$5.52M
4
CACI icon
CACI
CACI
+$4.78M
5
D icon
Dominion Energy
D
+$3.25M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$1.78M
2
ABT icon
Abbott
ABT
+$1.67M
3
AZTA icon
Azenta
AZTA
+$1.06M
4
LITE icon
Lumentum
LITE
+$601K
5
MSFT icon
Microsoft
MSFT
+$514K

Sector Composition

Rank Sector Weight
1 Healthcare 32.44%
2 Technology 24.17%
3 Industrials 19.52%
4 Utilities 8.63%
5 Communication Services 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LH icon
76
Labcorp
LH
$25.9B
$532K 0.11%
3,287
MBCN
77
DELISTED
Middlefield Banc Corp
MBCN
$512K 0.11%
+26,540
New +$490K
ITW icon
78
Illinois Tool Works
ITW
$84.5B
$502K 0.1%
2,600
SWKS icon
79
Skyworks Solutions
SWKS
$10.6B
$480K 0.1%
3,300
BRK.B icon
80
Berkshire Hathaway Class B
BRK.B
$1.13T
$469K 0.1%
+2,204
New +$451K
RDS.A
81
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$469K 0.1%
+18,623
New +$563K
REGN icon
82
Regeneron Pharmaceuticals
REGN
$80.8B
$448K 0.09%
800
ITRI icon
83
Itron
ITRI
$4.54B
$440K 0.09%
7,250
+3,350
+86% +$213K
AGCO icon
84
AGCO
AGCO
$7.2B
$431K 0.09%
5,800
DIS icon
85
Walt Disney
DIS
$181B
$421K 0.09%
3,396
+160
+5% +$20K
IBB icon
86
iShares Biotechnology ETF
IBB
$9.77B
$420K 0.09%
3,100
VNM icon
87
VanEck Vietnam ETF
VNM
$504M
$420K 0.09%
28,300
+9,700
+52% +$141K
VMW
88
DELISTED
VMware, Inc
VMW
$402K 0.08%
2,800
MTSI icon
89
MACOM Technology Solutions
MTSI
$23.7B
$400K 0.08%
11,750
+50
+0.4% +$1.82K
TXN icon
90
Texas Instruments
TXN
$261B
$400K 0.08%
2,800
BSV icon
91
Vanguard Short-Term Bond ETF
BSV
$44.6B
$389K 0.08%
4,679
+84
+2% +$6.98K
KRE icon
92
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$375K 0.08%
+10,500
New +$396K
EEFT icon
93
Euronet Worldwide
EEFT
$2.7B
$355K 0.07%
3,900
-650
-14% -$63.4K
SHW icon
94
Sherwin-Williams
SHW
$89.8B
$348K 0.07%
1,500
IQV icon
95
IQVIA
IQV
$39.3B
$347K 0.07%
2,200
-200
-8% -$31.3K
HOLX
96
DELISTED
Hologic
HOLX
$346K 0.07%
5,200
CMCSA icon
97
Comcast
CMCSA
$90B
$322K 0.07%
6,958
+1,494
+27% +$65K
NEE icon
98
NextEra Energy
NEE
$177B
$319K 0.07%
4,600
FELE icon
99
Franklin Electric
FELE
$4.84B
$312K 0.06%
5,300
+100
+2% +$5.68K
IPGP icon
100
IPG Photonics
IPGP
$3.84B
$297K 0.06%
1,750

Similar funds

John G. Ullman & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, John G. Ullman & Associates held 132 positions worth $483M, up 18% from $410M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

John G. Ullman & Associates deployed $54.1M of net new capital in Q3 2020, opening 23 new positions and adding to 33 existing holdings. Its largest new stake was CACI: 22,100 shares worth $4.71M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $1.78M trimmed.

  • John G. Ullman & Associates's largest Q3 2020 buy was CACI: 22,100 shares worth $4.71M.
  • John G. Ullman & Associates added most to Cisco in Q3 2020, an estimated $10.1M increase.
  • John G. Ullman & Associates's biggest Q3 2020 reduction was Thermo Fisher Scientific, cutting an estimated $1.78M.
  • John G. Ullman & Associates fully exited Schwab US Large-Cap Growth ETF in Q3 2020, selling an estimated $227K.
  • John G. Ullman & Associates's ten largest holdings make up 37% of its $483M portfolio in Q3 2020.
  • John G. Ullman & Associates opened 23 new positions and closed 4 in Q3 2020.
  • John G. Ullman & Associates's portfolio value rose 18% quarter-over-quarter to $483M.

Based on John G. Ullman & Associates's 13F filing for Q3 2020, filed 6 Nov 2020.